Sale

Cellulite Treatment Market

Global Cellulite Treatment Market Share, Size, Analysis: By Treatment Type: Energy-Based Treatment, Non-Energy-Based Treatment; By Procedure Type: Non-invasive, Minimally Invasive, Topical; By Cellulite Type: Soft Cellulite, Hard Cellulite, Edematous Cellulite; By End User; Regional Analysis; Competitive Landscape; 2024-2032

Global Cellulite Treatment Market Outlook

The global cellulite treatment market size attained a value of nearly USD 1.94 billion in 2023. The market is anticipated to grow at a CAGR of 10.9% during the forecast period of 2024-2032 to reach a value of USD 4.91 billion by 2032. The growth of the market can be attributed to the high demand for cosmetic procedures and the presence of advanced healthcare infrastructure.

 

Cellulite Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Cellulite has a dimpled and lumpy appearance on the skin. Because of its texture, cellulite is also known as orange-peel skin. A low-fat diet, cessation of smoking, and an active lifestyle can assist in decreasing cellulite incidence. Various cellulite treatments are also available to help in the removal of cellulite. The cellulite treatment market can be divided on the basis of segments like treatment type, technique, and end-use.

 

Cellulite Treatment Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market can be broadly categorised on the basis of its end-use into:

  • Hospitals
  • Dermatology Clinics
  • Cosmetic Surgery Centres

The market can be classified on the basis of its treatment types into energy-based treatment and non-energy-based treatment. Energy-based treatment can be further subdivided into mechanical suction, mechanical suction and thermal, radiofrequency, ultrasound, cryolipolysis, and others.

The EMR report looks into the regional markets for cellulite treatment like North America, LATAM, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Market Analysis

The major driver of the cellulite treatment market is the growing prevalence of obesity. Approximately half of the world’s population is dissatisfied with their appearance, while three-fourth of the population sought treatment to rectify their appearance. These factors have been driving the market growth over the past five years.

Technological innovations and improvements, along with new product launches are expected to fuel the market demand. Social media promotions and advertisements are projected to influence a large customer base, which will accelerate the industry growth.

The major drivers for the industry in North America are the high awareness about the latest medical developments among prospective consumers and a well-developed health care infrastructure. The Asia Pacific market is anticipated to grow significantly as market players working in the aesthetic sector in countries like India and China are increasing their penetration. The high cost of the treatment restricts the growth of the consumer base, which can be a major limitation for this industry growth.

 

Cellulite Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global cellulite treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Cynosure, Inc. 
  • Cutera, Inc.
  • Nestlé S.A.
  • Merz, Inc.
  • Mentor Worldwide LLC
  • Fosun Pharmaceutical Co., Ltd. 
  • Allergan plc
  • Syneron Medical Ltd.
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Procedure Type
  • Cellulite Type
  • End User
  • Region
Breakup by Treatment Type
  • Energy-Based Treatment
  • Non-Energy Based Treatment
Breakup by Procedure Type
  • Non-invasive
  • Minimally Invasive
  • Topical
Breakup by Cellulite Type
  • Soft Cellulite
  • Hard Cellulite
  • Edematous Cellulite
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cutera
  • Nestle
  • Merz Pharmaceuticals, LLC
  • Inceler Medikal Co Ltd.
  • Shanghai Fosun Pharmaceutical Group Co. Ltd.
  • Hologic Inc.
  • Candela Corporation
  • Mentor Worldwide LLC
  • Zimmer Aesthetics
  • Tanceuticals
  • Nubway Co. Ltd.
  • Allergan

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Cellulite Diseases Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
    4.4    Global Contraceptive Drugs Product Landscape
5    Cellulite Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Cellulite Epidemiology (2016-2031)
    5.3    Europe Cellulite Epidemiology (2016-2031)
    5.4    Asia-Pacific Cellulite Epidemiology (2016-2031)
    5.5    Latin America Cellulite Epidemiology (2016-2031)
    5.6    Middle East & Africa Cellulite Epidemiology (2016-2031)
6    Global Cellulite Treatment Market Overview 
    6.1    Global Cellulite Treatment Market Historical Value (2017-2023) 
    6.2    Global Cellulite Treatment Market Forecast Value (2024-2032)
7    Global Cellulite Treatment Market Landscape
    7.1    Cellulite Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Cellulite Treatment: Product Landscape
        7.2.1    Analysis by Treatment Type
        7.2.2    Analysis by Procedure Type
        7.2.3    Analysis by Cellulite Type
        7.2.4    Analysis by End User
8    Cellulite Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Cellulite Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Cellulite Treatment Market Segmentation
    11.1    Global Cellulite Treatment Market by Treatment Type
        11.1.1    Market Overview
        11.1.2    Energy-Based Treatment
            11.1.2.1    Mechanical Suction and Thermal
            11.1.2.2    Radiofrequency
            11.1.2.3    Ultrasound
            11.1.2.4    Cry lipolysis
            11.1.2.5    Mechanical Suction
            11.1.2.6    Others
        11.1.3    Non-Energy Based Treatment
    11.2    Global Cellulite Treatment Market by Procedure Type
        11.2.1    Market Overview
        11.2.2    Non-invasive
        11.2.3    Minimally Invasive
        11.2.4    Topical
    11.3    Global Cellulite Treatment Market by Cellulite Type
        11.3.1    Market Overview
        11.3.2    Soft Cellulite
        11.3.3    Hard Cellulite
        11.3.4    Edematous Cellulite
    11.4    Global Cellulite Treatment Market by End User
        11.4.1    Market Overview
        11.4.2    Hospitals
        11.4.3    Specialty Clinics
        11.4.4    Ambulatory Surgical Centers
        11.4.5    Others
    11.5    Global Cellulite Treatment Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Cellulite Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Cellulite Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14     Asia Pacific Cellulite Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Cellulite Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Cellulite Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21     Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Cutera
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Nestle
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Merz Pharmaceuticals, LLC
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Inceler Medikal Co Ltd.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Shanghai Fosun Pharmaceutical Group Co. Ltd.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Hologic Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Candela Corporation
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Mentor Worldwide LLC
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Zimmer Aesthetics
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Tanceuticals
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Nubway Co. Ltd.
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Allergan 
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
24    Cellulite Treatment Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global cellulite treatment market reached a value of USD 1.94 million in 2023.

In the forecast period 0f 2024-2032, the industry is projected to grow at a CAGR of 10.9%.

The major factor which is expected to aid the industry growth includes the growing prevalence of obesity.

Technological innovations and improvements in the industry are expected to define the market growth in the coming years.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market.

The leading treatment types of cellulite treatment in the market are energy-based and non-energy based treatment.

Non-invasive and minimally invasive, among others, are the significant techniques of the product in the industry.

The major end use sectors in the market are hospitals, dermatology clinics and cosmetic surgery centres.

The major players in the market are Cynosure, Inc., Cutera, Inc., Nestlé S.A., Merz, Inc, Mentor Worldwide LLC, Fosun Pharmaceutical Co., Ltd., Allergan plc, and Syneron Medical Ltd., among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER